Optiver Holding
EDIT icon

Optiver Holding’s Editas Medicine EDIT Stock Holding History

Optiver Holding’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839 Sell
259
-260
-50% -$760 ﹤0.01% 2526
2026
Q1 		$1.28K Sell
519
-3
-0.6% -$6 ﹤0.01% 2006
2025
Q4 		$1.07K Sell
522
-117
-18% -$338 ﹤0.01% 2209
2025
Q3 		$2.22K Sell
639
-156
-20% -$435 ﹤0.01% 2344
2025
Q2 		$1.75K Hold
795
– – ﹤0.01% 1355
2025
Q1 		$922 Buy
795
+435
+121% +$640 ﹤0.01% 1283
2024
Q4 		$457 Buy
+360
New +$917 ﹤0.01% 1008
2024
Q3 		– Sell
-11
Closed -$51 – 982
2024
Q2 		$51 Buy
+11
New +$62 ﹤0.01% 883

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Optiver Holding's EDIT Position: Q2 2026 in Review

Optiver Holding reduced its Editas Medicine (EDIT) stake by 50% in Q2 2026, selling an estimated $760 and leaving 259 shares worth $839. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

Optiver Holding first reported a position in EDIT in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.22K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Optiver Holding held 259 shares of Editas Medicine worth $839 as of Q2 2026.
  • Optiver Holding sold 260 Editas Medicine shares in Q2 2026, an estimated $760.
  • Editas Medicine made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2526 holding.
  • Optiver Holding first reported a position in Editas Medicine in Q2 2024 and has held it in 8 quarters since.
  • Optiver Holding's Editas Medicine position peaked at $2.22K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.